The reported statements, read against the company's own industry.
Financials view
Market Capitalization
13.42BCNY
2.01B · vs all stocks (USD)
Updated Oct 22, 2026
Trailing P/E
239.18x
vs Aerospace & Defense peers
Updated Oct 22, 2026
Revenue (TTM)
4.37BCNY
654.20M · vs all stocks (USD)
Updated Oct 22, 2026
Profit Margin
1.30%
vs Aerospace & Defense peers
Updated Oct 22, 2026
Beta
0.8670x
vs all stocks
Updated Oct 22, 2026
52-Week Change
47.59%
vs all stocks
Updated Oct 22, 2026
Market Capitalization
13.42BCNY
2.01B · vs all stocks (USD)
Updated Oct 22, 2026
Enterprise Value
16.79BCNY
2.52B · vs all stocks (USD)
Updated Oct 22, 2026
Trailing P/E
239.18x
vs Aerospace & Defense peers
Updated Oct 22, 2026
Forward P/E
184.82x
vs Aerospace & Defense peers
Updated Oct 22, 2026
Price to Sales (TTM)
3.07x
vs Aerospace & Defense peers
Updated Oct 22, 2026
Price to Book (MRQ)
7.50x
vs Aerospace & Defense peers
Updated Oct 22, 2026
Enterprise to Revenue
3.85x
vs Aerospace & Defense peers
Updated Oct 22, 2026
Enterprise to EBITDA
40.70x
vs Aerospace & Defense peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 72.92×.Updated Oct 22, 2026
Gross Margin
17.37%
vs Aerospace & Defense peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 12.71%.Updated Oct 22, 2026
Profit Margin
1.30%
vs Aerospace & Defense peers
Updated Oct 22, 2026
Operating Margin
5.90%
vs Aerospace & Defense peers
Updated Oct 22, 2026
Return on Assets (TTM)
1.45%
vs Aerospace & Defense peers
Updated Oct 22, 2026
Return on Equity (TTM)
4.78%
vs Aerospace & Defense peers
Updated Oct 22, 2026
Revenue (TTM)
4.37BCNY
654.20M · vs all stocks (USD)
Updated Oct 22, 2026
Revenue per Share (TTM)
13.69CNYUpdated Oct 22, 2026
Quarterly Revenue Growth
8.80%
vs Aerospace & Defense peers
Updated Oct 22, 2026
Gross Profit (TTM)
555.13MCNY
83.16M · vs all stocks (USD)
Updated Oct 22, 2026
EBITDA (TTM)
230.28MCNY
34.50M · vs all stocks (USD)
Updated Oct 22, 2026
Net Income (TTM)
56.71MCNY
8.49M · vs all stocks (USD)
Updated Oct 22, 2026
Quarterly Earnings Growth (YoY)
161.70%
vs Aerospace & Defense peers
Updated Oct 22, 2026
Operating Cash Flow (TTM)
1.22BCNY
182.36M · vs all stocks (USD)
Updated Oct 22, 2026
Levered Free Cash Flow (TTM)
674.69MCNY
101.07M · vs all stocks (USD)
Updated Oct 22, 2026
5-Year Average Dividend Yield
0.09%
vs all stocks
Updated Oct 22, 2026
Payout Ratio
0.00%
vs Aerospace & Defense peers
Updated Oct 22, 2026
Minority Interest (Equity)
1.19BCNYFY2025 · Dec 31, 2025
Revenue
4.32BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
3.75BCNYFY2025 · Dec 31, 2025
Gross Profit
577.25MCNYFY2025 · Dec 31, 2025
Operating Income
256.39MCNY
38.41M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
166.16MCNYFY2025 · Dec 31, 2025
Income Tax Expense
25.90MCNYFY2025 · Dec 31, 2025
Net Income
140.26MCNYFY2025 · Dec 31, 2025
EBIT
224.81MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
614.24MCNYFY2025 · Dec 31, 2025
Research & Development
110.43MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
44.08MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
27.80MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
911.11KCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
58.64MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.1800CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.1800CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
338.21MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
338.21MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
140.26MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-79.38MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
706.11MCNYFY2025 · Dec 31, 2025
Free Cash Flow
288.11MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
574.14MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
140.26MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
59.50MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
62.32MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
444.03MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-418.00MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-418.00MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
1.68BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-2.23BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-37.94MCNYFY2025 · Dec 31, 2025
Other Financing Charges
55.01MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-533.22MCNYFY2025 · Dec 31, 2025
Shares Outstanding
330.13MSharesUpdated Oct 22, 2026
Float Shares
209.60MSharesUpdated Oct 22, 2026
% Held by Insiders
36.02%
vs all stocks
Updated Oct 22, 2026
% Held by Institutions
8.50%
vs all stocks
Updated Oct 22, 2026
Total Cash (MRQ)
369.09MCNY
55.29M · vs all stocks (USD)
Updated Oct 22, 2026
Total Cash per Share (MRQ)
1.12CNYUpdated Oct 22, 2026
Total Debt (MRQ)
1.79BCNY
268.37M · vs all stocks (USD)
Updated Oct 22, 2026
Total Debt to Equity (MRQ)
0.5912x
vs Aerospace & Defense peers
Updated Oct 22, 2026
Current Ratio (MRQ)
1.15x
vs Aerospace & Defense peers
Updated Oct 22, 2026
Book Value per Share (MRQ)
5.42CNYUpdated Oct 22, 2026
Total Assets
8.53BCNY
1.28B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
5.57BCNYFY2025 · Dec 31, 2025
Total Liabilities
5.56BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
2.97BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
869.85MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
4.69BCNYFY2025 · Dec 31, 2025
Cash
54.72MCNYFY2025 · Dec 31, 2025
Cash Equivalents
7.37MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
581.51MCNYFY2025 · Dec 31, 2025
Accounts Receivable
2.06BCNYFY2025 · Dec 31, 2025
Inventory
2.43BCNYFY2025 · Dec 31, 2025
Accounts Payable
3.28BCNYFY2025 · Dec 31, 2025
Short-term Debt
1.23BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
2.57MCNYFY2025 · Dec 31, 2025
Long-term Debt
670.39MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
11.25MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
330.13MCNYFY2025 · Dec 31, 2025
Retained Earnings
245.29MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
2.98BCNY
445.79M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
25.24CNYUpdated Oct 22, 2026
52-Week High
58.31CNYUpdated Oct 22, 2026
52-Week Change
47.59%
vs all stocks
Updated Oct 22, 2026
Beta
0.8670x
vs all stocks
Updated Oct 22, 2026
50-Day MA
38.22CNYUpdated Oct 22, 2026
200-Day MA
39.31CNYUpdated Oct 22, 2026
Avg 10-Day Volume
25.84MSharesUpdated Oct 22, 2026
Avg 30-Day Volume
20.26MSharesUpdated Oct 22, 2026
Diluted EPS (TTM)
0.1700CNYUpdated Oct 22, 2026
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Partial Recovery After Sharp DeclineUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedClose Below 40W SMA With Profitability
Partial Recovery After Sharp DeclineUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedClose Below 40W SMA With Profitability
Partial Recovery After Sharp DeclineUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedClose Below 40W SMA With Profitability